Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/05/2026 | Q4 | $2.5B | -- | -- | $1.67 | -- |
| 10/30/2025 | Q3 | $2.4B | $3B | $1.42 | $1.61 | -$0.18 |
| 07/31/2025 | Q2 | $2.5B | $3.1B | $1.48 | $1.77 | -$0.29 |
| 05/01/2025 | Q1 | $2.5B | $3B | $1.38 | $1.70 | -$0.32 |
| 02/06/2025 | Q4 | $2.3B | $2.8B | $1.21 | $1.49 | -$0.28 |
| 10/31/2024 | Q3 | $2.4B | $2.8B | $1.14 | $1.55 | -$0.41 |
| 08/01/2024 | Q2 | $2.3B | $2.8B | $1.10 | $1.49 | -$0.39 |
| 05/02/2024 | Q1 | $2.3B | $2.7B | $1.33 | $1.49 | -$0.15 |
| 02/08/2024 | Q4 | $2.2B | $2.6B | $0.65 | $1.29 | -$0.64 |
| 11/02/2023 | Q3 | $2B | $2.4B | $0.96 | $1.39 | -$0.43 |
| 08/03/2023 | Q2 | -- | $2.3B | $1.42 | -- | -- |
| 05/04/2023 | Q1 | -- | $2.4B | $1.17 | -- | -- |
| 02/02/2023 | Q4 | -- | $2.2B | $0.76 | -- | -- |
| 11/03/2022 | Q3 | -- | $2.2B | -$0.34 | -- | -- |
| 08/04/2022 | Q2 | -- | $2.3B | $0.99 | -- | -- |
| 05/05/2022 | Q1 | -- | $2.4B | $1.16 | -- | -- |
| 02/03/2022 | Q4 | -- | $2.3B | $2.70 | -- | -- |
| 10/28/2021 | Q3 | -- | $2.2B | $1.12 | -- | -- |
| 07/29/2021 | Q2 | -- | $3.3B | $2.22 | -- | -- |
| 04/29/2021 | Q1 | -- | $2.3B | $1.14 | -- | -- |
| 02/04/2021 | Q4 | -- | $2.1B | $0.93 | -- | -- |
| 10/29/2020 | Q3 | -- | $1.8B | $0.71 | -- | -- |
| 07/30/2020 | Q2 | -- | $1.8B | $0.95 | -- | -- |
| 04/30/2020 | Q1 | -- | $1.9B | $1.17 | -- | -- |
| 02/06/2020 | Q4 | -- | $1.6B | $0.80 | -- | -- |
| 10/31/2019 | Q3 | -- | $1.6B | $0.94 | -- | -- |
| 08/01/2019 | Q2 | -- | $1.5B | $0.83 | -- | -- |
| 05/02/2019 | Q1 | -- | $1.5B | $0.85 | -- | -- |
| 02/07/2019 | Q4 | -- | $1.6B | $1.07 | -- | -- |
| 10/31/2018 | Q3 | -- | $1.4B | $0.80 | -- | -- |
| 08/02/2018 | Q2 | -- | $1.5B | $0.78 | -- | -- |
| 05/03/2018 | Q1 | -- | $1.5B | $0.79 | -- | -- |
| 02/07/2018 | Q4 | -- | $1.3B | $2.09 | -- | -- |
| 11/02/2017 | Q3 | -- | $1.3B | $0.63 | -- | -- |
| 08/03/2017 | Q2 | -- | $1.4B | $0.70 | -- | -- |
| 05/03/2017 | Q1 | -- | $1.6B | $0.84 | -- | -- |
| 02/07/2017 | Q4 | -- | $1.4B | $0.59 | -- | -- |
| 11/01/2016 | Q3 | -- | $1.3B | $0.57 | -- | -- |
| 08/03/2016 | Q2 | -- | $1.4B | $0.60 | -- | -- |
| 05/04/2016 | Q1 | -- | $1.5B | $0.62 | -- | -- |
| 02/04/2016 | Q4 | -- | $1.1B | $0.66 | -- | -- |
Intercontinental Exchange, Inc. reported $3B worth of top line sales in its most recent quarter.
Intercontinental Exchange, Inc. announced earnings per share of $1.42 which represents a miss of analyst forecast a $1.61 per share.
Intercontinental Exchange, Inc. reported $2B that represents $3.53 per share over the last quarter.
Intercontinental Exchange, Inc.'s earnings are forecast to grow from $4.78 per share to $6.05 per share next year representing an increase of 44.7%.
Intercontinental Exchange, Inc.'s next earnings date is February 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.